Ophthalmic laser platform utilizing AI to enhance treatment planning of liposomal drug release

Eero Koivumäki; Laura Vesala; Jukka-Pekka Alanko; Timo Tanila; Petteri Uusimaa

doi:10.1117/12.2608600

7 March 2022 Ophthalmic laser platform utilizing AI to enhance treatment planning of liposomal drug release

Eero Koivumäki, Laura Vesala, Jukka-Pekka Alanko, Timo Tanila, Petteri Uusimaa

Proceedings Volume PC11941, Ophthalmic Technologies XXXII; PC119411F (2022) https://doi.org/10.1117/12.2608600
Event: SPIE BiOS, 2022, San Francisco, California, United States

Conference Poster

Abstract

Delivery of pharmaceuticals to the eye posterior poses a major challenge in ophthalmology. A promising drug delivery platform is indocyanine green (ICG) liposomes, which absorb near-infrared light resulting in a release of pharmaceutical molecules. The Modulight ophthalmic laser platform has been designed for treatments targeting the eye posterior and can also excite the absorption band of the liposomes. The laser connects with Modulight Cloud, enabling artificial intelligence (AI) based treatment planning by correlating the treatment parameters and success, which could increase the efficacy of future treatments. The same algorithms could deduce which treatment parameters work with which liposomal delivery parameters.

Conference Presentation

Citation Download Citation

Eero Koivumäki, Laura Vesala, Jukka-Pekka Alanko, Timo Tanila, and Petteri Uusimaa "Ophthalmic laser platform utilizing AI to enhance treatment planning of liposomal drug release", Proc. SPIE PC11941, Ophthalmic Technologies XXXII, PC119411F (7 March 2022); https://doi.org/10.1117/12.2608600

ACCESS THE FULL ARTICLE